β-D-Glucopyranoside, 2-[(4-methoxyphenyl)methyl]-3-thienyl (9CI)(647834-15-9)
- Name: β-D-Glucopyranoside, 2-[(4-methoxyphenyl)methyl]-3-thienyl (9CI)
- Synonyms:Atigliflozin;
- Molecular Formula:C18H22O7S
- Molecular Weight:382.43
- CAS Registry Number:647834-15-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.647834-15-9 尾-D-Glucopyranoside, 2-[(4-Methoxyphenyl)Methyl]-3-thienyl (9CI)
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.647834-15-9 Atigliflozin
Assay:98% Appearance:Solid powder Package:inquiry Storage:-20掳C Freezer Transportation:inquiry Application:Atigliflozin is a selective sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor. It has antihyperglycemic activity and is used as an antihyperglycaemic drug candidate.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 880486-59-9/Immunoglobulin G1, anti-(human CD40 (antigen)) (human-mouse monoclonal SGN-40 γ1-chain), disulfide with human-mouse monoclonal SGN-40 κ-chain, dimer
- 910649-32-0/Immunoglobulin G1, anti-(human interleukin 13) (human-mouse heavy chain), disulfide with human-mouse κ-chain, dimer
- 945228-49-9/Immunoglobulin G, anti-(tumor antigen 17-1A) (synthetic Fab fragment) fusion protein with bouganin (synthetic deimmunized)
- 780758-10-3/Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse h-R3 heavy chain), disulfide with human-mouse h-R3 κ-chain, dimer
- 185954-75-0/1-Decanol, 3-methoxy-, (3R)-
- 281214-27-5/1,4-Butanediol, 2,3-dimethyl-, 1,4-bis(4-methylbenzenesulfonate), (2R,3R)-
- 441002-17-1/Benzenesulfonic acid, 2-nitro-, 4-chlorobutyl ester
- 721946-42-5/Diphtheria toxin CRM107 (Corynebacterium diphtheriae precursor) conjugate with transferrin (human) (9CI)
- 884604-91-5/Ceramidase, glucosyl- (human HT-1080 cell)
- 885051-90-1/Pegloticase
- 892497-01-7/1,4-Diazabicyclo[2.2.2]octane, homopolymer, N-oxides, bromoacetic acid-quaternized
- 898830-54-1/Sitimagene ceradenovec
- 915019-08-8/L-Lysine, L-α-glutamyl-L-alanyl-L-arginyl-L-prolyl-L-alanyl-L-leucyl-L-leucyl-L-threonyl-L-seryl-L-arginyl-L-leucyl-L-arginyl-L-phenylalanyl-L-isoleucyl-L-prolyl-
- 934216-54-3/Immunoglobulin G1, anti-(vascular endothelial growth factor receptor type VEGFR-2) Fab' fragment (human-mouse monoclonal CDP791 γ1-chain), disulfide with human-mouse monoclonal CDP791 κ-chain, bis(maleimide) cross-linked dimer, 20-kilodalton pegylated
- 869881-54-9/Cytokine receptor BAFF-R (human extracellular domain-containing fragment BR3) fusion protein with immunoglobulin G1 (human Fc domain-containing fragment), dimer
- 295371-00-5/Heat-shock protein HSP 65 (Mycobacterium bovis strain BCG) fusion protein with transcription factor E7 (human papillomavirus 16) (9CI)
- 473553-86-5/DNA (synthetic human adenovirus 5 human fibroblast growth factor 4 gene-containing 35506-nucleotide fragment ZK 205368)
- 1345973-49-0/AB-001
- 647834-15-9/β-D-Glucopyranoside, 2-[(4-methoxyphenyl)methyl]-3-thienyl (9CI)
- 76610-92-9/(6R,7S)-7-[[(2R,3S)-2-(4-Ethyl-2,3-dioxo-1-piperazinylcarbonylamino)-3-hydroxybutyryl]amino]-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- 913976-27-9/Poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy-, diester with 21N6,21'N6-[[(N2,N6-dicarboxy-L-lysyl-β-alanyl)imino]bis(1-oxo-2,1-ethanediyl)]bis[N-acetylglycylglycyl-L-leucyl-L-tyrosyl-L-alanyl-L-cysteinyl-L-histidyl-L-methionylglycyl-L-prolyl-L-isoleucyl-L-threonyl-3-(1-naphthalenyl)-L-alanyl-L-valyl-L-cysteinyl-L-glutaminyl-L-prolyl-L-leucyl-L-arginyl-N-methylglycyl-L-lysinamide] cyclic (6→15),(6'→15')-bis(disulfide)
- 893428-72-3/4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-, (2E)-2-butenedioate (1:2)
- 390800-88-1/2-Pyrazinecarboxamide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-methylbutylidene]imino[(1S)-2-oxo-1-(phenylmethyl)-2,1-ethanediyl]]]tris-
- 39570-96-2/L-Isoleucine, N-[N-[N-[(4-methylphenylsulfonyl]-S-(phenylmethyl)-L-cysteinyl]-L-tyrosyl]-, hydrazide (9CI)
- 149456-98-4/Methanesulfonamide, N-[4-[2-(formylamino)acetyl]-5-methoxy-2-phenoxyphenyl]-
- 149457-03-4/Methanesulfonamide, N-[4-[2-(formylamino)acetyl]-5-hydroxy-2-phenoxyphenyl]-
- 1198178-65-2/Cyclopropanecarboxamide, 1-amino-N-(cyclopropylsulfonyl)-2-ethyl-, (1R,2R)-, 4-methylbenzenesulfonate (1:1)
- 120788-03-6/Ethanethioic acid, S-(tetrahydro-1-oxido-3-thienyl) ester, (1R-cis)- (9CI)
- 123664-84-6/Methanesulfonamide, N-(5-methoxy-2-phenoxyphenyl)-
- 1001859-46-6/RiferMinogene PecaplasMid